Career Enhancement Program

项目摘要 纽约大学黑色素瘤孢子职业提升计划（CEP）将准备独立的研究人员 研究黑色素瘤的转化研究职业。为了实现这一目标，CEP将选择、支持和 引导个人专注于成为黑色素瘤的领先翻译研究人员。的主任 CEP，Seth Orlow博士，纽约大学Langone Health（NYULH）皮肤科系主任， 在培养翻译科学家方面取得了成功。纽约大学黑色素瘤孢子CEP将 通过提供经济援助和学术支持，为优秀的候选人提供长达2年的支持 指导这将使获奖者能够建立与黑色素瘤相关的成功研究， 同时提供了一个坚实的基础，以进一步发展全面的研究项目内的孢子。的CEP 将通过招聘和支持，培养和发展黑色素瘤转化研究的人才管道， 有前途的初级或上升的教师，除了更成熟的研究人员有可能成为 专注于黑色素瘤转化研究的独立研究人员。CEP将监测， 监督和指导为CEP选择的每个人，以确保研究者朝着 在黑色素瘤转化研究中成功的独立职业生涯，除了利用获奖者， 计划和合作，以建立实现这一目标所需的技能。CEP坚定地致力于 在各级培训妇女和任职人数不足的少数族裔候选人，使其成为独立人士 investigators.独特的优势，将有利于CEP获奖者包括现有的正式课程 由纽约大学提供，导致科学硕士学位的转化研究和大量的 在多个专业领域有成就的导师。CEP在主题上与纽约大学黑色素瘤 SPORE的首要使命是使用个性化生物标志物优化黑色素瘤的临床管理 患者，并与SPORE的计划和项目高度整合。这一专题整合将 使CEP能够最大限度地提高获奖者的职业发展。

PROJECT SUMMARY The NYU Melanoma SPORE Career Enhancement Program (CEP) will prepare investigators for independent translational research careers to study melanoma. To accomplish this goal, the CEP will select, support, and guide individuals focused on becoming leading translational researchers in melanoma. The Director of the CEP, Dr. Seth Orlow, Chairman of the Department of Dermatology at NYU Langone Health (NYULH), has an established track record of success in training translational scientists. The NYU Melanoma SPORE CEP will support outstanding candidates for up to 2 full years by providing both financial assistance and academic guidance. This will enable awardees to establish successful investigations related to melanoma, and simultaneously provide a solid foundation to further develop full research projects within the SPORE. The CEP will nurture and grow the pipeline of talent in melanoma translational research by recruiting and supporting promising junior or rising faculty in addition to more established investigators with the potential to become accomplished independent investigators focused on melanoma translational research. The CEP will monitor, oversee, and mentor each individual chosen for the CEP to ensure the investigator’s progress towards a successful independent career in melanoma translational research, in addition to availing awardees to programs and collaborations to build the skills necessary to achieve this end. The CEP is strongly committed to training women and underrepresented minority candidates at all levels for careers as independent investigators. Unique strengths that will be beneficial to CEP awardees include existing formal coursework offered by NYU that leads to a Master of Science degree in translational research and a large pool of accomplished mentors across multiple specialties. The CEP is thematically aligned to the NYU Melanoma SPORE’s overarching mission to use personalized biomarkers to optimize clinical management of melanoma patients, and is highly integrated with the programs and projects of the SPORE. This thematic integration will enable the CEP to maximize the progress of the awardees careers.